Navigation Links
The Brain & Behavior Research Foundation awards $4 million in NARSAD Grants
Date:3/27/2014

NEW YORK CITY (March 27, 2014)The Brain & Behavior Research Foundation today announced its 2014 NARSAD Independent Investigator Grants, which will award $4 million in funding to 40 mid-career scientists from 33 institutions in nine countries. Selected by the Foundation's Scientific Council, comprised of 146 leading experts across disciplines in brain and behavior research including two Nobel Prize winners, the grants fund basic research, new technologies and next generation therapies for schizophrenia, major affective disorders, and other serious mental illnesses.

The Foundation's Independent Investigator Grants provide $50,000 per year for up to two years to support investigators during the critical period between the initiation of research and the receipt of sustained funding. The grants are part of the ongoing efforts of the Brain & Behavior Research Foundation to support scientists at every stage of their career by funding cutting-edge research for the understanding, early detection, treatment, prevention and cure of mental illness, including anxiety, autism, bipolar disorder, depression, post-traumatic stress disorder, obsessive compulsive disorder and schizophrenia.

"We are delighted to be able to support the work of these scientists who will apply powerful new technologies and insights to understanding, treating and curing mental illnesses that affect one in four people," says Jeffrey Borenstein, M.D., President and CEO of the Brain & Behavior Research Foundation. 'Tackling illnesses that affect the brain remains one of science's most daunting challenges. Every year we build upon a growing body of knowledge about the brain and its functions that bring us closer to finding cures."

The Foundation's Independent Investigator Grants are given for basic research (understanding what happens in the brain to cause mental illness); new technologies that advance or create new ways of studying and understanding the brain; and next generation therapies that reduce symptoms and retrain the brain.

"The investigations supported by NARSAD Independent Investigator Grants are cumulatively and exponentially advancing what is known about the brain and how to treat its illnesses," said Scientific Council Member and Chair, Independent Investigator Grant Selection Committee, Robert M. Post, M.D., George Washington University, who notes more than half of the recipients also received Young Investigator Grants from the Foundation early in their careers. "By expanding our knowledge of genetics and epigenetics, brain circuitry, neural pathways, and how these impact behavior, we are steadily increasing the possibilities for those with mental illness to live full and productive lives."

According to Dr. Post, the range of project proposals this year was exceptional in its variety of new approaches to understand and treat mental illness. For a full list and description of Independent Investigator Grants, visit http://bbrfoundation.org/NARSAD-II-Grants.
'/>"/>

Contact: Laura Wells
lwells@bbrfoundation.org
646-681-4877
Brain & Behavior Research Foundation
Source:Eurekalert

Related medicine news :

1. USF study finds stem cell combination therapy improves traumatic brain injury outcomes
2. US headache sufferers get $1 billion worth of brain scans each year, U-M study finds
3. Brain mapping confirms patients with schizophrenia have impaired ability to imitate
4. Critical role of one gene to our brain development
5. Halting immune response could save brain cells after stroke
6. New stroke research combines brain stimulation, gait training
7. Nicotine withdrawal weakens brain connections tied to self-control over cigarette cravings
8. Blasts may cause brain injury even without symptoms
9. Study identifies possible new target for future brain cancer drugs
10. Study reveals mechanisms cancer cells use to establish metastatic brain tumors
11. Brainstem discovered as important relay site after stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer ... Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As part of ... anatomic and molecular pathology workflow solution, as well as its new precision medicine ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, ... and business owners in and around the Hampton Roads metropolitan region, is joining ... forms of domestic violence. , There are multiple categories of domestic violence – ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017  Noble ... coverage on ESSA Pharma Inc. (Nasdaq: EPIX ... Biotechnology Research, Kumar Raja , PhD. ... treatments for castration resistant prostate cancer (CRPC). Its lead ... selectively blocks the amino-terminal domain of the androgen receptor, ...
Breaking Medicine Technology: